Last update 01 Nov 2024

Shanghai Enkai Cell Technology Co., Ltd.

Joint Venture Company | Private Company|
2020|
Shanghai Shi, China

Overview

Basic Info

Introduction
NK CellTech Co., Ltd., also known as Unicar-Therapy, operates as a biotechnological entity concentrating on the advancement of innovative cellular immunotherapy technology. Anchored by the mission to tackle major clinical therapeutic challenges, Unicar-Therapy is dedicated to delivering precise immunotherapeutic solutions and has developed an array of proprietary, intelligent natural killer (NK) cell products.

Tags

Neoplasms
Infectious Diseases
Endocrinology and Metabolic Disease
Immune cell therapy
CAR-NK
Fusion protein

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Immune cell therapy6
CAR-NK3
Fusion protein2
Bispecific antibody1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
8
3
Preclinical
IND Approval
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NK-010
Ovarian Cancer
More
IND Approval
NK-042
Advanced Malignant Solid Neoplasm
More
IND Approval
NK-043
Neoplasms
More
Preclinical
NK-011
Neoplasms
More
Preclinical
NK-062
Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free